Mizuho raised the firm’s price target on Herbalife (HLF) to $9 from $8 and keeps a Neutral rating on the shares. The company’s Q3 adjusted EBITDA beat on benefits from savings while global volume points remained soft, the analyst tells investors in a research note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter